{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "A Randomised Controlled Trial Comparing Bioactive Glass and Allograft for Benign Bone Lesions in Children"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "This pragmatic multicenter randomised controlled trial compared cyst recurrence after intralesional curettage and filling with allograft versus bioactive glass (BG-S53P4; Bonalive) in children aged 4 to 16 years."
      },
      "Participants": {
        "score": 2,
        "evidence": "in children aged 4 to 16 years. Conducted in four university hospitals in a Scandinavian country"
      },
      "Intervention": {
        "score": 2,
        "evidence": "compared cyst recurrence after intralesional curettage and filling with allograft versus bioactive glass (BG-S53P4; Bonalive)"
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "the primary outcome was the volume of recurrent cyst at 2-year follow-up"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed using sealed envelopes, and allocation was concealed."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding was not possible due to the distinct imaging characteristics of the materials."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "51 were randomised between October 2012 and February 2019"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "51 were randomised between October 2012 and February 2019 to undergo filling with morselized allograft (26) or bioactive glass (25)"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Twelve (46%) in the allograft group and 10 (40%) in the bioactive glass group developed a recurrence (OR = 0.79, 95% CI = 0.25 to 2.56, p = 0.77)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No significant adverse events were reported."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "The trial was registered at ClinicalTrials.gov (NCT04737590)"
      },
      "Funding": {
        "score": 1,
        "evidence": "funded by foundations and national state research funding"
      }
    },
    "total_score": 20,
    "max_score": 25
  },
  "model": "gpt-4o"
}